保德國際發展(00372.HK)擬投資百慕達投資控股業務
格隆匯4月21日丨保德國際發展(00372.HK)公佈,於2020年4月21日,公司、目標公司股東及目標公司訂立不具約束力的指示性條款協議,據此,公司擬透過於目標公司的可換股票據認購或其他類似適當及共同協定的工具於目標公司投資(即潛在投資)。
據悉,目標公司為於百慕達註冊成立的有限公司,其主要從事投資控股業務。目標公司乃由目標公司股東全資擁有。目標公司正收購百慕達一間持牌銀行的全部股權。
集團將繼續對目標集團公司進行盡職調查。指示性條款協議不具法律約束力,而指示性條款協議項下之潛在投資之完成須待(其中包括)執行有關潛在投資的最終協議及獲得相關監管機構的批准後,方可作實。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.